About Rachel Liberatore, Ph.D.
Form D filings for RenBio in 2024 list Rachel Liberatore, Ph.D. as president and chief scientific officer, director.
Rachel Liberatore, Ph.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Rachel Liberatore, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rachel Liberatore, Ph.D. works with at each company, as listed on that company's latest Form D.
RenBio, Inc. · Form D, Sep 6, 2024
JD
Jaap Goudsmit, M.D., Ph.D.
Director
ZD
Zhi Hong, Ph.D.
Director
DT
Donald Tang
Director
AR
Annelyn O'Rourke
Executive officer
WS
Walter Wang, Sr.
Director